PMID- 23716053 OWN - NLM STAT- MEDLINE DCOM- 20140108 LR - 20211203 IS - 1098-6596 (Electronic) IS - 0066-4804 (Print) IS - 0066-4804 (Linking) VI - 57 IP - 8 DP - 2013 Aug TI - Interrogating a hexokinase-selected small-molecule library for inhibitors of Plasmodium falciparum hexokinase. PG - 3731-7 LID - 10.1128/AAC.00662-13 [doi] AB - Parasites in the genus Plasmodium cause disease throughout the tropic and subtropical regions of the world. P. falciparum, one of the deadliest species of the parasite, relies on glycolysis for the generation of ATP while it inhabits the mammalian red blood cell. The first step in glycolysis is catalyzed by hexokinase (HK). While the 55.3-kDa P. falciparum HK (PfHK) shares several biochemical characteristics with mammalian HKs, including being inhibited by its products, it has limited amino acid identity (~26%) to the human HKs, suggesting that enzyme-specific therapeutics could be generated. To that end, interrogation of a selected small-molecule library of HK inhibitors has identified a class of PfHK inhibitors, isobenzothiazolinones, some of which have 50% inhibitory concentrations (IC50s) of <1 muM. Inhibition was reversible by dilution but not by treatment with a reducing agent, suggesting that the basis for enzyme inactivation was not covalent association with the inhibitor. Lastly, six of these compounds and the related molecule ebselen inhibited P. falciparum growth in vitro (50% effective concentration [EC50] of >/= 0.6 and <6.8 muM). These findings suggest that the chemotypes identified here could represent leads for future development of therapeutics against P. falciparum. FAU - Harris, Michael T AU - Harris MT AD - Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, USA. FAU - Walker, Dawn M AU - Walker DM FAU - Drew, Mark E AU - Drew ME FAU - Mitchell, William G AU - Mitchell WG FAU - Dao, Kevin AU - Dao K FAU - Schroeder, Chad E AU - Schroeder CE FAU - Flaherty, Daniel P AU - Flaherty DP FAU - Weiner, Warren S AU - Weiner WS FAU - Golden, Jennifer E AU - Golden JE FAU - Morris, James C AU - Morris JC LA - eng SI - SWISSPROT/Q02155 GR - R15 AI075326/AI/NIAID NIH HHS/United States GR - U54 HG005031/HG/NHGRI NIH HHS/United States GR - U54HG005031/HG/NHGRI NIH HHS/United States GR - 2R15AI075326/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130528 PL - United States TA - Antimicrob Agents Chemother JT - Antimicrobial agents and chemotherapy JID - 0315061 RN - 0 (Antimalarials) RN - 0 (Azoles) RN - 0 (Benzothiazoles) RN - 0 (Enzyme Inhibitors) RN - 0 (Isoindoles) RN - 0 (Organoselenium Compounds) RN - 0 (Protozoan Proteins) RN - 0 (Recombinant Proteins) RN - 0 (Small Molecule Libraries) RN - 40X2P7DPGH (ebselen) RN - EC 2.7.1.1 (Hexokinase) SB - IM MH - Amino Acid Sequence MH - Antimalarials/*pharmacology MH - Azoles/pharmacology MH - Benzothiazoles/*pharmacology MH - Dose-Response Relationship, Drug MH - Enzyme Inhibitors/pharmacology MH - Glycolysis MH - Hexokinase/*antagonists & inhibitors MH - Inhibitory Concentration 50 MH - Isoindoles MH - Molecular Sequence Data MH - Organoselenium Compounds/pharmacology MH - Parasitic Sensitivity Tests MH - Plasmodium falciparum/*drug effects/enzymology/growth & development MH - Protozoan Proteins/*antagonists & inhibitors MH - Recombinant Proteins/metabolism MH - Small Molecule Libraries/*pharmacology MH - Structure-Activity Relationship PMC - PMC3719756 EDAT- 2013/05/30 06:00 MHDA- 2014/01/09 06:00 PMCR- 2014/02/01 CRDT- 2013/05/30 06:00 PHST- 2013/05/30 06:00 [entrez] PHST- 2013/05/30 06:00 [pubmed] PHST- 2014/01/09 06:00 [medline] PHST- 2014/02/01 00:00 [pmc-release] AID - AAC.00662-13 [pii] AID - 00662-13 [pii] AID - 10.1128/AAC.00662-13 [doi] PST - ppublish SO - Antimicrob Agents Chemother. 2013 Aug;57(8):3731-7. doi: 10.1128/AAC.00662-13. Epub 2013 May 28.